304 related articles for article (PubMed ID: 28852271)
1. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
Park H; Choi Y; Jung CG; Park HS
Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Tan JHY; Hsu AAL
Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
[TBL] [Abstract][Full Text] [Related]
3. From "Samter's Triad" to "NERD": The Long and Winding Road to Understanding Aspirin-Exacerbated Respiratory Disease.
Tilles SA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):xiii-xiv. PubMed ID: 27712770
[No Abstract] [Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E
Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
[TBL] [Abstract][Full Text] [Related]
6. [The value of aspirin challenge tests in the diagnosis of non-steroidal anti-inflammatory drugs-exacerbated respiratory disease].
Xiao H; Zhang L; Lin H; Xiao YL; Zhang HT; Jia QR; Xu F; Meng J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Aug; 58(8):741-746. PubMed ID: 37550033
[No Abstract] [Full Text] [Related]
7. Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management.
Imam KH; Woessner KM
Pol Arch Intern Med; 2023 Sep; 133(9):. PubMed ID: 37548592
[TBL] [Abstract][Full Text] [Related]
8. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Lee HY; Ye YM; Kim SH; Ban GY; Kim SC; Kim JH; Shin YS; Park HS
Allergy; 2017 Apr; 72(4):616-626. PubMed ID: 27805264
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
Williams AN
Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?
Kowalski ML
Curr Opin Pulm Med; 2019 Jan; 25(1):64-70. PubMed ID: 30489335
[TBL] [Abstract][Full Text] [Related]
11. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
Morales DR; Guthrie B; Lipworth BJ; Jackson C; Donnan PT; Santiago VH
Allergy; 2015 Jul; 70(7):828-35. PubMed ID: 25855099
[TBL] [Abstract][Full Text] [Related]
12. [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].
Förster-Ruhrmann U; Behrbohm W; Pierchalla G; Szczepek AJ; Fluhr JW; Olze H
HNO; 2019 Aug; 67(8):620-627. PubMed ID: 31069402
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and aspirin desensitization in Thai patients with a suggestive history of NSAID-exacerbated respiratory disease.
Wongsa C; Sompornrattanaphan M; Tantilipikorn P; Thongngarm T
Asian Pac J Allergy Immunol; 2022 Sep; 40(3):247-253. PubMed ID: 31677617
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.
Makowska J; Lewandowska-Polak A; Kowalski ML
Curr Allergy Asthma Rep; 2015 Aug; 15(8):47. PubMed ID: 26149590
[TBL] [Abstract][Full Text] [Related]
15. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.
Cahill KN; Cui J; Kothari P; Murphy K; Raby BA; Singer J; Israel E; Boyce JA; Laidlaw TM
Am J Respir Crit Care Med; 2019 Sep; 200(6):704-711. PubMed ID: 30978291
[No Abstract] [Full Text] [Related]
16. Recent Updates in Understanding NSAID Hypersensitivity.
Minaldi E; Cahill K
Curr Allergy Asthma Rep; 2023 Mar; 23(3):181-188. PubMed ID: 36757490
[TBL] [Abstract][Full Text] [Related]
17. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
[TBL] [Abstract][Full Text] [Related]
18. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
Celejewska-Wójcik N; Wójcik K; Ignacak-Popiel M; Ćmiel A; Tyrak K; Gielicz A; Kania A; Nastałek P; Sanak M; Mastalerz L
Allergy; 2020 Apr; 75(4):831-840. PubMed ID: 31803947
[TBL] [Abstract][Full Text] [Related]
19. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
20. Bronchial epithelial cell transcriptome shows endotype heterogeneity of asthma in patients with NSAID-exacerbated respiratory disease.
Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Licholai S; Aab A; Rebane A; Bochenek G
J Allergy Clin Immunol; 2023 Apr; 151(4):953-965. PubMed ID: 36395984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
